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Effect of Environmental Conditions on theConcentration of
Tear Inflammatory Mediators During Contact Lens Wear
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Margarita Calonge, MD,*† José M. González-Méijome, PhD,‡ and María J. González-García, PhD*†
Purpose: To analyze the inﬂuence of environmental conditions on
the concentrations of tear inﬂammatory mediators during contact
lens (CL) wear.
Methods: Fifty-four CL wearers completed 4 visits combining the
bilateral use of omaﬁlcon A or comﬁlcon A CL and a 90-minute
exposure to 2 environmental conditions: standard [50% relative
humidity (RH), 23°C, 930 mb] or adverse (5% RH, localized air
ﬂow, 23°C, 750 mb). Four microliters of tears was collected by
capillarity from each subject. Changes in concentration of epidermal
growth factor (EGF); interleukin (IL)-1 receptor antagonist, IL-1b,
IL-2, IL-4, IL-6, and IL-8; tumor necrosis factor (TNF) a; monocyte
chemoattractant protein-1; and matrix metalloproteinase (MMP)-9
were analyzed. The effects of the environment, CL type, and
symptoms were evaluated using a 3-way mixed analysis of
variance with repeated measures.
Results: Under the standard condition, EGF signiﬁcantly increased
[0.36; 95% conﬁdence interval (CI), 0.08 to 0.64], and IL-1b (20.48;
95% CI, 20.84 to 20.12) and IL-2 (20.48; 95% CI, 20.87 to 20.09)
signiﬁcantly decreased. Under the adverse condition, IL-6 signiﬁcantly
increased (0.35; 95% CI, 0.09 to 0.62). Comparing conditions, EGF
change was signiﬁcantly lower (P = 0.02) and IL-1b, IL-2, IL-6, and
TNF-a changes were signiﬁcantly higher (P # 0.04) under the adverse
condition. Additionally, IL-1b signiﬁcantly decreased with comﬁlcon A
(20.51; 95% CI, 20.88 to 20.15), being signiﬁcantly lower (P = 0.01)
than the change with omaﬁlcon A (0.06; 95% CI, 20.23 to 0.35).
Conclusions: The secretion of several tear inﬂammatory mediators
during CL wear differs depending on the environmental conditions
and the CL type used. These outcomes might help to understand the
effect of the environment and CL materials on the ocular surface of
CL wearers.
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Contact lens (CL) wearers are daily exposed to artiﬁciallycontrolled environments such as air-conditioned ofﬁces,
buildings, or aircraft cabins. These indoor spaces involve
challenging environmental conditions such as low relative
humidity (RH), air ﬂow, and/or decreased barometric pressure.
Airplane cabins in particular, because of their characteristics
regarding RH, air renewal, etc., represent an adverse environ-
ment, which combines these conditions all together.1 Previous
studies have shown that adverse conditions elicit the develop-
ment of dryness symptoms in dry eye patients and CL
wearers.2–8 These desiccating scenarios also have a negative
impact on clinical signs of the ocular surface,2,9–11 including
a decrease in tear volume and stability and an increase in
conjunctival hyperemia and corneal staining. As the presence
of a CL on the ocular surface reduces tear ﬁlm stability,12 CL
wear in adverse environments is likely to exacerbate further
these ocular symptoms.
It is known that some CL-related complications are
somewhat mediated through the release of tear inﬂammatory
mediators, such as giant papillary conjunctivitis, which presents
altered tear levels of eotaxin,13 or corneal neovascularization,
which is mediated by vascular endothelial growth factor.14
Likewise, the concentration of several tear molecules, such as
interleukin (IL)-6, IL-8, and epidermal growth factor (EGF),15–18
has been shown to be upregulated in CL wearers. Moreover, CL
type could be key in this, as differences have been found
between hard and soft CL wearers.16,19 These ﬁndings suggest
that there may be an underlying inﬂammatory process related to
CL wear. The expression of some tear proteins has also been
found altered in subjects with CL-related discomfort20; this
discomfort can lead to decreased wearing time and discontinu-
ation of CL wear.21
Exposure to desiccating environments exacerbates dry
eye clinical signs2,9,10 and increases certain proinﬂammatory
molecules regardless of the presence of dry eye disease.10
We hypothesized that transient exposure to an artiﬁcially
adverse environment could also elicit the expression of some
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proinﬂammatory mediators in CL wearers. With that in mind,
the purpose of the study was to analyze the inﬂuence of
controlled environmental conditions, CL type, and CL-related
symptoms on the concentration of tear inﬂammatory media-
tors in CL wearers.
MATERIALS AND METHODS
Ethical Issues
The study complied with the tenets of the Declaration
of Helsinki, and the protocol was approved by the University
of Valladolid Ethics Committee. The nature of the research
and protocols was explained to the subjects before written
informed consent was obtained during the preliminary visit.
Participants
Fifty-four soft CL wearers [20 men and 34 women;
mean age6 standard deviation (SD), 20.06 7.3 years; range,
18–45] were included. The criteria for selecting subjects were
age between 18 and 45 years, a myopic spherical equivalent
between 21.00 and 25.00 diopters (D), astigmatism error
less than or equal to 0.75 D, and having worn CLs for at least
the last 6 months before the study. Exclusion criteria were
taking systemic or ocular medication (different from artiﬁcial
tears), ocular abnormalities, and a history of ophthalmic
disease or surgery, including refractive procedures.
The ocular surface disease index (OSDI) questionnaire
was administered to categorize subjects based on their
discomfort with their habitual CL wear (discomfort-based
grouping). Those having an OSDI score ,15 were classiﬁed
as asymptomatic, and those having a score $15 were
classiﬁed as symptomatic.22
At the preliminary visit (V0), all subjects were ﬁtted
with the 2 study CLs—omaﬁlcon A and comﬁlcon A
(CooperVision, Irvine, CA)—to conﬁrm that both types of
CLs ﬁt each subject properly. These CLs were chosen
because of their similarities in CL parameters and physical
properties of their CL blister solutions (osmolarity, pH,
surface tension, and viscosity).23
The right eye was chosen as the study eye for tear
molecule analysis, despite the fact that the CLs were
worn bilaterally.
Study Protocol
The recruited subjects were exposed to 2 different
environmental conditions wearing each of the 2 CL types for
each exposure, making a total of 4 visits by each subject, thus
volunteers wore each CL type under 2 different environmental
conditions. At the beginning of each visit, subjects were
bilaterally ﬁtted with the randomized CL, wore the CLs for
15 minutes, and immediately after performing the tear
collection, they were exposed to the randomized environmental
condition. The order in which participants were exposed with
each CL under each environmental condition was randomized,
and visits were spaced between 2 and 5 days. Subjects were
instructed not to use their CLs or artiﬁcial tears from 24 hours
before starting the study until after they had ﬁnished all visits.
Environmental Conditions
Subjects were exposed within an environmental cham-
ber (CERLab, IOBA, University of Valladolid)9 to 2 different
controlled environmental conditions: (1) “standard condition”
(50% RH, 23°C temperature, and 930 mb of atmospheric
pressure, which is the average pressure in Valladolid, Spain)
and (2) “adverse condition” (5% RH, localized air ﬂow—
mean air velocity 0.43 m/s, 23°C temperature, and 750 mb
atmospheric pressure—similar to that typically found within
an airplane cabin during ﬂight).24–26 Environmental chamber
exposure lasted 90 minutes, while the individuals were seated
watching a ﬁlm on a 55-inch television (LG Electronics Inc,
Gumi, South Korea).
Tear Sample Collection
Tear sample collection was performed twice per visit:
(1) after wearing the CL for 15 minutes and just before the
exposure to each environmental condition (PRE) and (2)
immediately after 90 minutes of exposure (POST).
A 4-mL sample of basal tears was collected from the
external canthus using a glass capillary tube (Drummond
Scientiﬁc, Broomall, PA) in a nontraumatic way, trying to
avoid reﬂex tear secretion as much as possible. Tear samples
were diluted (1/10) in assay buffer and frozen as described
previously.27
Analysis of Tear Molecule Concentration
The concentrations of EGF; IL-1 receptor antagonist
(RA); IL-1b, IL-2, IL-4, IL-6, IL-8; tumor necrosis factor
(TNF) a; monocyte chemoattractant protein-1 (MCP-1); and
matrix metalloproteinase-9 (MMP-9) were measured simul-
taneously with a 10-plex immunobead-based assay (10X-plex
magnetic human cytokine/MMP-9 panel; Millipore, Billerica,
MA) in a Luminex IS-100 instrument (Luminex Corp, Austin,
TX). The samples were analyzed according to the manufac-
turer’s procedure as previously described.27 The minimum
detectable concentrations (in picograms per milliliter) for
molecules analyzed were as follows: 1.23 for EGF, IL-1RA,
IL-4, IL-8, MCP-1, and MMP-9; 1.18 for TNF-a; 1.16 for IL-
2; 1.12 for IL-6; and 1.05 for IL-1b.
In some cases, the assayed molecule was undetectable.
Cytokine levels below the limit of detection were imputed
using the robust regression on order statistics method
introduced by Helsel28 and implemented in the NADA
(nondetects and data analysis) package.29 However, mole-
cules detected in less than 50% of the samples in every
condition were not analyzed further because the statistical
analysis might be biased.30
Data Analysis
The sample size was calculated with the online freeware
“Power Analysis for ANOVA Designs”.31 It took into account
that 2 groups and 4 clinical scenarios were compared, level of
signiﬁcance was determined as 0.05, effect size as 0.40,32 and
statistical power as 80%. Based on these parameters, sample
size calculated was 25 subjects for each symptomatic and
asymptomatic group. We included 2 additional subjects per
Cornea  Volume 35, Number 9, September 2016 Tear Mediators, Environment, and Contact Lenses
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 1193
Copyright  2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
group in case of dropout; therefore, the total sample size was 27
subjects for each group.
Sample distributions for quantitative variables were
analyzed using the Mann–Whitney U test, whereas qualitative
variables were compared using either the x2 test or the Fisher
exact test if cell sizes were too small.
Tear molecule analysis data were log-transformed (log
2), which normalizes the tear concentration data, before
conducting statistical analysis. The change in tear molecule
concentration between both moments of environment expo-
sure (PRE and POST) was calculated as the difference with
the following formula: change = log2(Ypost) 2 log2(Ypre),
where “Ypost” is the “Y” tear molecule concentration after the
exposure and “Ypre” is the “Y” tear molecule concentration
before the exposure. The main advantage of this formula is
that equal positive and negative change values will be
symmetric and reciprocal, that is, a change of 21 means that
the amount of the molecule is half of the previous value and
a change of +1 means double. The “change” numerical value
thus obtained was considered as the main variable. Changes
in molecules whose 95% conﬁdence interval (CI) did not
include the “0” value were considered statistically signiﬁcant.
A multivariable analysis, a repeated-measures analysis
of variance (ANOVA), was used to analyze the effect of
environmental condition (standard and adverse), CL type
(omaﬁlcon A and comﬁlcon A), and discomfort-based
grouping (asymptomatic and symptomatic subjects), and
their interactions, on the change in tear molecule concen-
tration. Two intrasubject (environmental condition and CL
type) and 1 intersubject (discomfort-based grouping) factors,
and their interactions, were considered. Pairwise compar-
isons were based on Student t tests. P-values were adjusted
for multiple testing by the Holm method.33
Statistical analysis was carried out by a licensed
statistician (coauthor I. Fernández) using R Statistical Soft-
ware.34 Package Car35 was used to ﬁt repeated-measures
ANOVA models. P values less than or equal to 0.05 were
considered statistically signiﬁcant.
RESULTS
The OSDI-based classiﬁcation divided the participants
into an asymptomatic group (11 males and 16 females;
white; mean age 25.8 6 6.0 years) and a symptomatic group
(9 males and 18 females; white; mean age 28.8 6 8.3 years).
None of the participants suffered from systemic diseases.
Clinical variables included at the preliminary visit for both
groups are shown in Table 1. The subject sex and age
did not differ signiﬁcantly (P = 0.573 and P = 0.215,
respectively) between the groups. Likewise, no signiﬁcant
differences were found between the groups in terms of CL
wear time (P = 0.476), 7.1 6 5.3 years for the asymptomatic
group and 6.7 6 4.5 years for the symptomatic one. CL
wear schedule did not differ between groups either (P =
0.538). In the asymptomatic group, there were 3, 2, and 22
volunteers whose CL schedule was daily, biweekly, and
monthly, respectively. In the symptomatic group, there were
6, 3, and 18 volunteers following the same CL schedules,
respectively. In contrast, we found signiﬁcant differences
(P = 0.01) between groups for artiﬁcial tear use before the
study; no participant from the asymptomatic group used
them, whereas 7 out of 27 symptomatic wearers did.
The mean percentage of detection of each molecule
(including visits 1–4, before and after environmental
exposure) was as follows: EGF (95%), IL-1RA (94%),
IL-1b (50%), IL-2 (56%), IL-4 (49%), IL-6 (71%), IL-8
(95%), TNF-a (53%), MCP-1 (96%), and MMP-9 (78%).
Each molecule concentration obtained during each visit is
detailed in Supplemental Digital Content 1 (see Table,
http://links.lww.com/ICO/A436).
Effect of the “Environment”
Analyzing the changes provoked by each condition, the
standard condition exposure provoked a signiﬁcant increase
in the concentration of EGF (0.36; 95% CI, 0.08 to 0.64) and
a decrease of IL-1b (20.48; 95% CI, 20.84 to 20.12) and
IL-2 (20.48; 95% CI, 20.87 to 20.09). A signiﬁcant
increase of IL-6 level (0.35; 95% CI, 0.09 to 0.62) was
observed after the adverse condition exposure (Fig. 1).
Comparing adverse and standard conditions, the adverse
condition provoked signiﬁcantly lower change than the
standard condition for EGF (P = 0.02) and signiﬁcantly
higher for IL-1b (P = 0.029), IL-2 (P = 0.016), IL-6 (P =
0.045), and TNF-a (P = 0.029) (Fig. 1).
The other molecules analyzed (IL-1RA, IL-4, IL-8,
MCP-1, and MMP-9) were unaffected by the environment
(P . 0.05).
Effect of the “CL Type”
Tear levels of IL-1b signiﬁcantly decreased when
wearing the comﬁlcon A CL (20.51; 95% CI, 20.88 to
20.15), whereas no signiﬁcant change was reported with
omaﬁlcon A (0.06; 95% CI, 20.23 to 0.35) (Fig. 2).
Moreover, the change of IL-1b was signiﬁcantly different
comparing both CLs (P = 0.014) (Fig. 2).
The CL type did not show any effect on the other tear
molecules (P . 0.05): EGF, IL-1RA, IL-2, IL-4, IL-6, IL-8,
TNF-a, MCP-1, and MMP-9.
















Visual acuity (logarithm of
the minimum angle of
resolution)
20.06 6 0.05 20.05 6 0.05 0.45
BUT (s) 6.5 6 3.5 4.6 6 3.1 0.03*
Corneal staining (Oxford
scale)
0 (0–0) 0 (0–0) 0.77
Schirmer I test (mm) 24.6 6 10.6 21.0 6 11.5 0.28
*P-value , 0.05.
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Effect of the “Symptom-Based Grouping”
No signiﬁcant effects of the symptom-based grouping were
found in any tear molecule analyzed (P. 0.05): EGF, IL-1b, IL-
1RA, IL-2, IL-4, IL-6, IL-8, TNF-a, MCP-1, and MMP-9.
Effect of the Interaction “Environment and
CL Type”
Under the standard condition, there was a signiﬁcant
decrease in IL-1b concentration when wearing comﬁlcon A CL
(21.05; 95% CI,21.56 to20.54), but no change was observed
with omaﬁlcon A (0.08; 95% CI,20.40 to 0.57). These changes
in IL-1b concentration were signiﬁcantly different (P = 0.001)
comparing both CLs (Fig. 3). No effects were found for this
interaction under the adverse condition (Fig. 3).
No signiﬁcant results were found for the remaining
molecules (P . 0.05): EGF, IL-1RA, IL-2, IL-4, IL-6, IL-8,
TNF-a, MCP-1, and MMP-9, although the change in MMP-9
showed a borderline signiﬁcant effect (P = 0.055).
Effect of the Interaction “Environment and
Symptom-Based Grouping”
No signiﬁcant effects were found for this interaction in
any tear molecule analyzed (P . 0.05): EGF, IL-1b, IL-1RA,
IL-2, IL-4, IL-6, IL-8, TNF-a, MCP-1, and MMP-9.
FIGURE 1. Environmentally produced changes in EGF, IL-1b, IL-2, IL-6, and TNF-a concentrations. *Significant (P , 0.05) dif-
ference between the changes produced by the 2 environments. †Significant (P , 0.05) environmentally produced change in
molecule concentration.
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Effect of the Interaction “CL Type and
Symptom-Based Grouping”
A signiﬁcant decrease was found for asymptomatic
subjects with comﬁlcon A for IL-1b (–0.90; 95% CI, –1.40 to
20.40), but not with omaﬁlcon A. A signiﬁcant increase was
found with omaﬁlcon A for IL-6 (0.50; 95% CI, 0.17 to 0.83)
and IL-8 (0.46; 95% CI, 0.07 to 0.86), but not with comﬁlcon A
(Fig. 4). Moreover, changes found for both CLs were signiﬁ-
cantly different for IL-1b (P = 0.001), IL-6 (P = 0.040), and IL-8
(P = 0.016). No effects were found for this interaction in
symptomatic subjects (Fig. 4).
The other tear molecules (EGF, IL-1RA, IL-2, IL-4,
IL-6, IL-8, TNF-a, MCP-1, and MMP-9) were not affected
by this interaction (P . 0.05).
DISCUSSION
In this study we have found that, after 2 hours of CL
wear, an environmentally adverse condition provoked a more
inﬂammatory proﬁle (lower EGF and higher IL-1b, IL-2,
IL-6, and TNF-a concentrations) than a standard condition in
CL wearers. Surprisingly, it is the standard condition that
mainly affected the molecule levels, provoking an increase of
FIGURE 2. Changes produced in IL-1b concentration by
CL type. *Significant (P , 0.05) difference between
the changes produced by the 2 lenses. †Significant (P ,
0.05) change produced by comfilcon A in molecule con-
centration.
FIGURE 3. Changes in IL-1b concentration produced
by the interaction between the environment and CL
type. *Significant (P , 0.05) difference between the
changes produced by the 2 lenses under the standard
condition. †Significant (P , 0.05) change in molecule
concentration produced by comfilcon A under the standard
condition.
FIGURE 4. Changes in IL-1b, IL-6, and IL-8 concentrations
produced by the interaction between CL type and symptom-
based grouping. *Significant (P , 0.05) difference between
the changes produced by the 2 lenses in the asymptomatic
group. †Significant (P , 0.05) change produced by the CL
type in the molecule concentration.
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EGF and decrease of IL-1b and IL-2, whereas the adverse
condition only provoked an increase of IL-6. In addition,
there were also differences between CLs evaluated: patients
wearing comﬁlcon A showed a decrease of IL-1b concentra-
tion, but this reduction was not seen with omaﬁlcon A.
Our outcomes showed that the standard condition
caused an effect that could be considered “protective”
because EGF tear levels signiﬁcantly increased but the
concentration of inﬂammatory cytokines such as IL-1b and
IL-2 signiﬁcantly decreased. In contrast, this effect was not
observed after our volunteers were exposed to the adverse
condition. Instead, the changes in molecule concentrations
constituted a “proinﬂammatory” scenario because IL-6 tear
levels signiﬁcantly increased. Besides, changes observed in
EGF, IL-1b, IL-2, IL-6, and TNF-a concentrations were
signiﬁcantly different from those observed after the standard
condition, which further shows the “proinﬂammatory” effect
of this desiccating condition simulating an air ﬂight. All these
results are in agreement with previous outcomes from our
group where the effect of the environmental condition was
studied in both healthy and dry eye patients.9,10 These studies
have shown that under an adverse condition (simulating an
aircraft cabin), EGF concentration was signiﬁcantly reduced
and IL-6 tear levels were signiﬁcantly increased in both
healthy10 and dry eye patients,9 an effect that was not found
under a standard condition either.9 Although we found no
signiﬁcant decrease in EGF concentration under the adverse
condition, these levels were signiﬁcantly lower than those
found under the standard condition. These similarities
between these studies9,10 and the ﬁndings in our CL users
further conﬁrm the potential of desiccating indoor environ-
ments to stimulate an inﬂammatory response not only in
healthy subjects and dry eye patients but also in CL wearers.
Our results showed that the IL-1b tear concentration was
signiﬁcantly reduced after wearing the comﬁlcon A in compar-
ison with the omaﬁlcon A, and also when wearing the comﬁlcon
A under the standard condition in comparison with the other 3
situations. Despite the fact that no studies have yet detected IL-1b
altered in CL wearers, it has been found to be increased in tears in
dry eye patients, and even shows a positive correlation with dry
eye syndrome severity.36 Thus, the decrease of IL-1b found
might indicate that the use of comﬁlcon A under a standard
condition may provide a less proinﬂammatory environment than
the other situations. This result might be related to the higher
oxygen permeability of comﬁlcom A (a silicone hydrogel CL),
which in combination with a standard condition, produces a less
proinﬂammatory effect on the ocular surface.
Similarly, the outcomes of the interaction between CL
type and symptom-based grouping revealed that the IL-1b,
IL-6, and IL-8 tear concentrations were dependent on the CL
type but only for asymptomatic subjects. IL-1b has been
found elevated in tears of dry eye patients,36 IL-6 has been
shown to be a mediator of pain,37 and IL-8 can induce
hyperalgesia38; thus, changes in their concentrations might be
related to CL discomfort. Therefore, our results may indicate
that in symptomatic subjects the effect of the CL material
would be minor because the ocular surface is already altered,
whereas in asymptomatic wearers, CLs can produce different
inﬂammatory levels, depending on the CL type used.
This study has some limitations. First, only 2 CL types
were tested; other commercially available CL types could
behave differently on the eye. Therefore, the results obtained
are largely related to the CLs themselves and should be
applied with caution to other CL designs and materials.
Second, tear collection was always performed when the
subjects were wearing CLs; consequently, our results describe
the effect that the environmental conditions have on the ocular
surface during CL wear. Therefore, as no tear collection was
done without CL wear, the effect that these environmental
conditions have on these subjects in the absence of CL wear
was not studied and is unknown. And ﬁnally, CL wear has
been found to decrease the tear ﬁlm break-up time39 and the
tear meniscus volume40 and to increase tear osmolarity.41
These ﬁndings might be associated with a reduction in the
aqueous component of tears and could have an impact on the
concentration of tear molecules (eg, cytokine levels) because
of the change in the dilution rate, affecting our results. Further
studies in CL wearers about the effect of environmental
conditions including some other CL types and tear collection
at different times and in the absence of CL wear are warranted.
In conclusion, the secretion of several tear inﬂamma-
tory mediators during CL wear differs depending on the
environmental conditions, standard or adverse, and the CL
type, omaﬁlcon A or comﬁlcon A. This might help to
understand the effect of the environment and CL materials
on the ocular surface of CL wearers. Differences observed
between symptomatic and nonsymptomatic CL wearers will
also provide insights for future strategies to overcome CL
discomfort and inﬂammatory events in CL wearers.
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